Twenty-seven adult patients were identified as having community-acquired Klebsiella pneumo-niae meningitis. The K. pneumoniae isolates, collected from cerebrospinal fluid samples, were tested for in vitro antimicrobial susceptibilities. The prognostic factors of these 27 patients were also analysed. All of the third- and fourth-generation cephalosporins tested, as well as mono-bactam, carbapenem and ciprofloxacin, had good activities against the isolated K. pneumoniae strains. None of the clinical isolates was detected as being an extended-spectrum β-lactamase-producing pathogen. Among the third- and fourth-generation cephalosporins, ceftizoxime, cefepime, ceftriaxone and cefotaxime had superior activities, with MIC90s about four- to eight-...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
Because of treatment failure with the use of third-generation cephalosporins for penicillin-resistan...
Twenty-seven adult patients were identified as having community-acquired Klebsiella pneumo-niae meni...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complic...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complic...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complic...
Klebsiella pneumoniae producing Klebsiella pneumoniae carbapenemase (KPC) has been associated with s...
Objectives: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains of...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of compli...
Objectives: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains of...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
Objectives: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains of...
In a recent article in this Journal, Caniça et al.1 reported in vitro activities for extended-spectr...
Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complicated intra-a...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
Because of treatment failure with the use of third-generation cephalosporins for penicillin-resistan...
Twenty-seven adult patients were identified as having community-acquired Klebsiella pneumo-niae meni...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complic...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complic...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complic...
Klebsiella pneumoniae producing Klebsiella pneumoniae carbapenemase (KPC) has been associated with s...
Objectives: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains of...
Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of compli...
Objectives: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains of...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
Objectives: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains of...
In a recent article in this Journal, Caniça et al.1 reported in vitro activities for extended-spectr...
Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complicated intra-a...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
OBJECTIVES: Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing strains...
Because of treatment failure with the use of third-generation cephalosporins for penicillin-resistan...